Work

Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML

Year: 2014

Type: article

Study design: Clinical Trial

Source: International Journal of Hematology

DOI: 10.1007/s12185-014-1503-4

Authors: Giridharan Ramsingh, Peter Westervelt, Ali McBride, Keith Stockerl-Goldstein, Ravi Vij, Mark Fiala, Geoffrey Uy, Amanda Cashen, John F. DiPersio, Camille N. Abboud

Institutions: University of Southern California, Washington University in St. Louis, University of Arizona, University of Arizona Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: Specialized Program of Research Excellence (SPORE) in Leukemia

OpenAlex ID: W2131862838

FWCI: 3.31

Cites: 19

Cited by: 34

Related to: 10